Ignite Creation Date:
2025-12-24 @ 10:57 PM
Ignite Modification Date:
2026-01-01 @ 10:25 PM
Study NCT ID:
NCT04659369
Status:
TERMINATED
Last Update Posted:
2024-04-09
First Post:
2020-11-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Pharmacokinetic, Safety, Immunogenicity and Efficacy of CMAB819 and Nivolumab in R/M HNSCC
Sponsor:
Taizhou Mabtech Pharmaceutical Co.,Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-09-24
Start Date Type:
ACTUAL
Primary Completion Date:
2023-10-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-10-16
Completion Date Type:
ACTUAL
First Submit Date:
2020-11-19
First Submit QC Date:
None
Study First Post Date:
2020-12-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-07
Last Update Post Date:
2024-04-09
Last Update Post Date Type:
ACTUAL